XIFAXAN
- Product NDC
- 55154-6777
- 11-digit product format
- 551546777
- Labeler code
- 55154
- Product ID
- 55154-6777_bb4000c2-f76a-42a8-8791-6730b748a3d4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- rifaximin
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Cardinal Health 107, LLC
- Application
- NDA021361
- Marketing category
- NDA
- Marketing start
- 2010-05-01
- Substance
- RIFAXIMIN
- Active strength
- 550 mg/1
- Pharmacologic classes
- Rifamycin Antibacterial [EPC], Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- XIFAXAN
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RIFAXIMIN | 550 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | L36O5T016N |
| Rxcui | 856664, 856666 |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 55154-6777-8 | XIFAXAN | 360 in 1 BOTTLE, PLASTIC | TABLET | 360 | | 14 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 55154-6777 | XIFAXAN (RIFAXIMIN) TABLET [CARDINAL HEALTH 107, LLC] | 13 | Current NDC, Legacy NDC, 1 package rows | 20240718_7afafa63-3236-4212-9589-045db6b01c0b.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 55154-6777-8 | 55154677708 | 360 TABLET in 1 BOTTLE, PLASTIC (55154-6777-8) | 360 tablet | 2010-05-01 | 0000-00-00 | No | No | Current |